Dengue viral infections

Article English OPEN
Gurugama Padmalal ; Garg Pankaj ; Perera Jennifer ; Wijewickrama Ananda ; Seneviratne Suranjith (2010)
  • Publisher: Wolters Kluwer Medknow Publications
  • Journal: Indian Journal of Dermatology, volume 55, issue 1, pages 68-78 (issn: 0019-5154, eissn: 1998-3611)
  • Related identifiers: pmc: PMC2856379, doi: 10.4103/0019-5154.60357
  • Subject: epidemiology | treatment | IJD Symposium | Dermatology | RL1-803 | Dengue | clinical features

Dengue viral infections are one of the most important mosquito-borne diseases in the world. Presently dengue is endemic in 112 countries in the world. It has been estimated that almost 100 million cases of dengue fever and half a million cases of dengue hemorrhagic fever (DHF) occur worldwide. An increasing proportion of DHF is in children less than 15 years of age, especially in South East and South Asia. The unique structure of the dengue virus and the pathophysiologic responses of the host, different serotypes, and favorable conditions for vector breeding have led to the virulence and spread of the infections. The manifestations of dengue infections are protean from being asymptomatic to undifferentiated fever, severe dengue infections, and unusual complications. Early recognition and prompt initiation of appropriate supportive treatment are often delayed resulting in unnecessarily high morbidity and mortality. Attempts are underway for the development of a vaccine for preventing the burden of this neglected disease. This review outlines the epidemiology, clinical features, pathophysiologic mechanisms, management, and control of dengue infections.
Share - Bookmark